Expanding COVID-19 Vaccination —Optimizing Use and Maximizing Efficacy

This Viewpoint proposes ways to maximize vaccine efficacy and allocation given the rise of coronavirus variants and authorization of a Johnson& Johnson vaccine, including reserving the latter for younger healthier populations, boosting it with a single-dose messenger RNA (mRNA) vaccination, and single mRNA immunization of people with prior documented SARS-CoV-2 infection.
Source: JAMA - Category: General Medicine Source Type: research